Work

Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors

Year: 2016

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-016-3148-x

Authors: Martin J. Edelman, Rena Lapidus, Josephine Feliciano, Miroslav Styblo, Jan H. Beumer, Tao Liu, Jogarao Gobbru

Institutions: University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of North Carolina at Chapel Hill, University of Pittsburgh, UPMC Hillman Cancer Center, University of Maryland, Baltimore

Language: English

Topic: Telomeres, Telomerase, and Senescence

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Institute, University of Pittsburgh, National Cancer Institute

Awards: Telemere Targeted Therapy in Lung Cancer, UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT, Cancer Center Support Grant

OpenAlex ID: W2520368057

FWCI: 0.228

Cites: 24

Cited by: 13

Related to: 10